¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

¸íÁöº´¿ø The 3nd MYONGJI INTERNATIONAL LIVER SYMPOSIUM : 2018-09-07

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
¸íÁöº´¿ø The 3nd MYONGJI INTERNATIONAL LIVER SYMPOSIUM : 2018-09-07
±³À°ÀÏÀÚ : 2018-09-07
±³À°Àå¼Ò : ¸íÁöº´¿ø ³óõȦ  
±³À°ÁÖÁ¦ : The 3nd MYONGJI INTERNATIONAL LIVER SYMPOSIUM      
ÁÖÃÖ±â°ü :¸íÁöº´¿ø
´ã´çÀÚ : ÀÌÀåÇö
¿¬¶ôó : 031-810-5024  
À̸ÞÀÏ : jasonuranos@mjh.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 4Á¡  
Áö¿ª : °æ±âµµ
±³À°½Ã°£ : 4 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 09¿ù 07ÀÏ ¸íÁöº´¿ø ³óõȦ 13:00~13:30 Á¢¼ö ¹× Àλ縻  Prof. Hyo-Suk Lee(Myongji Hospital Goyangsi Korea) 
±³À°½Ã°£ 09¿ù 07ÀÏ ¸íÁöº´¿ø ³óõȦ 13:30~13:45 Changing Epidemiology: Increasing burden of non-B, non-C liver diseases in Korea  Prof. Young-Suk Lim(Asan Medical Center Seoul Korea) 
±³À°½Ã°£ 09¿ù 07ÀÏ ¸íÁöº´¿ø ³óõȦ 13:45~14:00 Changing Epidemiology: Increasing burden of non-B,non-C liver diseases in Japan  Prof. Junko Tanaka(Hiroshima University Hiroshima Japan) 
±³À°½Ã°£ 09¿ù 07ÀÏ ¸íÁöº´¿ø ³óõȦ 14:00~14:15 Changing Epidemiology: Increasing burden of non-B,non-C liver diseases in USA  Prof. W. Ray Kim(Stanford University Palo Alto USA) 
±³À°½Ã°£ 09¿ù 07ÀÏ ¸íÁöº´¿ø ³óõȦ 14:15~14:30 Comparison of practice guidelines of NAFLD between AASLD 2017, EASL 2016 and Asia-Pacific Working Party 2017; similarities and differences  Prof. Hitoshi Yoshiji(Nara Medical University Nara Japan) 
±³À°½Ã°£ 09¿ù 07ÀÏ ¸íÁöº´¿ø ³óõȦ 14:30~14:45 Characteristics of NASH-associated HCC and its clinical impacts in Korea  Dr. Eun Ju Cho(Seoul National University Seoul Korea) 
±³À°½Ã°£ 09¿ù 07ÀÏ ¸íÁöº´¿ø ³óõȦ 14:45~15:00 Characteristics of NASH-associated HCC and its clinical impacts in Japan  Dr. Soo Ki Kim(Kobe-Asahi Hospital Kobe Japan) 
±³À°½Ã°£ 09¿ù 07ÀÏ ¸íÁöº´¿ø ³óõȦ 15:00~15:15 Characteristics of NASH-associated HCC and its clinical impacts in USA  Prof. W. Ray Kim(Stanford University Palo Alto USA) 
È޽Ġ09¿ù 07ÀÏ ¸íÁöº´¿ø ³óõȦ 15:15~15:30 Coffee Break  () 
±³À°½Ã°£ 09¿ù 07ÀÏ ¸íÁöº´¿ø ³óõȦ 15:30~15:45 Changing epidemiology of acute viral hepatitis: Hepatitis E in Korea  Prof. Sook Hyang Jeong(Seoul National University Bundang Hospital Seongnam Korea) 
±³À°½Ã°£ 09¿ù 07ÀÏ ¸íÁöº´¿ø ³óõȦ 15:45~16:00 Changing epidemiology of acute viral hepatitis: Hepatitis E in Japan  Dr. Jong-Hon Kang(Teine Keijinkai Hospital Sapporo Japan) 
±³À°½Ã°£ 09¿ù 07ÀÏ ¸íÁöº´¿ø ³óõȦ 16:00~16:20 Liver Immunology: Immunotherapy of HCC vs transplantation tolerance - Immunotherapy of HCC with check-point inhibitors  Dr. Su Jong Yu(Seoul National University Seoul Korea) 
±³À°½Ã°£ 09¿ù 07ÀÏ ¸íÁöº´¿ø ³óõȦ 16:20~16:40 Liver Immunology: Immunotherapy of HCC vs transplantation tolerance - Operational transplantation tolerance with Treg cell therapy  Prof. Hideki Ohdan(Hiroshima University Hiroshima Japan) 
±³À°½Ã°£ 09¿ù 07ÀÏ ¸íÁöº´¿ø ³óõȦ 16:40~17:00 Systemic therapy of HCC on the horizon other than check-point inhibitors - Oncolytic virotherapy of HCC: Pros and cons  Prof. Takeshi Yamada(University of Tsukuba Tsukuba Japan) 
±³À°½Ã°£ 09¿ù 07ÀÏ ¸íÁöº´¿ø ³óõȦ 17:00~17:30 Approach to the risk and prevention of HCC in the era of precision medicine - Is the time ripe for application of GWAS in clinical hepatology?  Prof. Naoya Kato(Chiba University Chiba Japan) 
±³À°½Ã°£ 09¿ù 07ÀÏ ¸íÁöº´¿ø ³óõȦ 17:30~17:45 Summary of the 3rd MILS  Prof. W. Ray Kim(Stanford University Palo Alto USA) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ¸íÁöº´¿ø The 3nd MYONGJI INTERNATIONAL LIVER SYMPOSIUM : 2018-09-07""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ¼­¿ï´ëÇб³º´¿ø ¾È°ú ±Ý¿ä¼¼¹Ì³ª : 2018-09-07
´ÙÀ½±Û 2018³âµµ ´ëÇѺñ¸¸ÇÐȸ ±¹Á¦Çмú´ëȸ(ICOMES 2018) - 09/07 : 2018-09-07
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20895 ¼­¿ï ´ëÇѼҾƽÅÀåÇÐȸ (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-01 0 4 2024-05-28
20894 ´ëÀü Ãæ³²´ëÇб³º´¿ø 2024³â °³¿øÀÇ¿Í ÇÔ²²ÇÏ´Â ³»°ú ¿¬¼ö°­Á : 2024-06-30 0 7 2024-05-28
20893 ¼­¿ï ´ëÇѳúÁ¹ÁßÇÐȸ 6¿ù º¸¼ö±³À° : 2024-06-30 0 112 2024-05-27
20892 ¼­¿ï (¿Â¶óÀÎ)Á¦22Â÷ ¼­¿ïƯº°½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-30 0 17 2024-05-27
20891 °æ±â (¿Â¶óÀÎ)Á¦21Â÷ °æ±âµµÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-30 0 61 2024-05-27
20890 Àü³² 2024³â ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ¿¬¼ö°­Á : 2024-06-30 0 12 2024-05-27
20889 Ãæ³² ´ëÇÑÁ¤Çü¿Ü°úÃÊÀ½ÆÄÇÐȸ - Á¦19Â÷ Ãá°èÇмú´ëȸ ¹× Á¦38Â÷ ±Ù°ñ°Ý°è ÃÊÀ½ÆÄ¿öÅ©¼¥ (Basic Course) : 2024-06-30 0 8 2024-05-27
20888 ºÎ»ê Á¦3ȸ ´ëÇÑÅõ¼®Çùȸ ºÎ»êÁöȸ ½ÉÆ÷Áö¾ö : 2024-06-29 0 7 2024-05-27
20887 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7ȸ A to Z (Atherosclerosis to Zero) ¿¬¼ö°­Á ÇÁ·Î±×·¥ : 2024-06-29 0 27 2024-05-27
20886 °æ±â 2024³âµµ ³²¾çÁÖ½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-29 0 1 2024-05-27
20885 ¼­¿ï (¿Â¶óÀÎ)Á¦14ȸ ´ëÇÑ°¨¿°ÇÐȸ Æò»ý±³À° ÇÁ·Î±×·¥ °¨¿°Áúȯ ÃÖ½ÅÁö°ß : 2024-06-29 0 8 2024-05-27
20884 ¼­¿ï Á¦24Â÷ ´ëÇѽÅÀåÇÐȸ ½ÅÀ̽Ŀ¬±¸È¸ ¿¬¼ö°­Á : 2024-06-29 0 1 2024-05-27
20883 ¼­¿ï 2024 ¼±Ãµ¼º Ⱦ°æ¸· Å»Àå ÄÚȣƮ (K-CDH) ±³À°¼¼¹Ì³ª : 2024-06-29 0 10 2024-05-27
20882 ¼­¿ï 2024 ¿©¼º½ÉÀåÁúȯ¿¬±¸È¸ ÇÏ°è ½ÉÆ÷Áö¾ö : 2024-06-29 0 7 2024-05-27
20881 °­¿ø 2024 ³âµµ Á¤Çü¿Ü°úÇб³½Ç °³¿øÀÇ¿¬¼ö°­Á : 2024-06-29 0 11 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷